References
- Bejarano V, Quinn M, Conaghan PG, et al. Effect of the early use of the anti-tumor necrosis factor adalimumab on the prevention of job loss in patients with early rheumatoid arthritis. Arthritis Rheum 2008;59:1467-74
- Wolfe F, Michaud K, Choi HK, et al. Household income and earnings losses among 6396 persons with rheumatoid arthritis. J Rheumatol 2005;32:1875-83
- McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med 2011;365:2205-19
- Michaud K, Messer J, Choi HK, et al. Direct medical costs and their predictors in patients with rheumatoid arthritis: a three-year study of 7527 patients. Arthritis Rheum 2003;48:2750-62
- Kleinman NL, Cifaldi MA, Smeeding JE, et al. Annual incremental health benefit costs and absenteeism among employees with and without rheumatoid arthritis. J Occup Environ Med 2013;55:240-4
- Simons WR, Rosenblatt LC, Trivedi DN. The economic consequences of rheumatoid arthritis: analysis of Medical Expenditure Panel Survey 2004, 2005, and 2006 data. J Occup Environ Med 2012;54:48-55
- Ozminkowski RJ, Burton WN, Goetzel RZ, et al. The impact of rheumatoid arthritis on medical expenditures, absenteeism, and short-term disability benefits. J Occup Environ Med 2006;48:135-48
- Birnbaum H, Pike C, Kaufman R, et al. Employer model of workplace impacts of anti-TNF therapy for rheumatoid arthritis. J Occup Environ Med 2009;51:1167-76
- Birnbaum H, Pike C, Kaufman R, et al. Societal cost of rheumatoid arthritis patients in the US. Curr Med Res Opin 2010;26:77-90
- Mishel L, Shierholz H. A decade of flat wages: the key barrier to shared prosperity and a rising middle class [Internet]. 2013. Economic Policy Institute (EPI). Washington, DC. http://s1.epi.org/files/2013/BP365.pdf. Accessed October 23, 2013
- Sacks DW, Stevenson B, Wolfers J. Subjective well-being, income, economic development and growth [Internet]. 2010. The National Bureau of Economic Research (NBER). Cambridge, MA. http://www.nber.org/papers/w16441.pdf. Accessed October 23, 2013
- Chen Y, Jobanputra P, Barton P, et al. A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness. Heal Technol Assess 2006;10:iii-iv, xi-xiii, 1-229
- Birnbaum HG, Pike C, Banerjee R, et al. Changes in utilization and costs for patients with rheumatoid arthritis, 1997 to 2006. Pharmacoeconomics 2012;30:323-36
- Kirchhoff T, Ruof J, Mittendorf T, et al. Cost of illness in rheumatoid arthritis in Germany in 1997-98 and 2002: cost drivers and cost savings. Rheumatology (Oxford) 2011;50:756-61
- Birnbaum H, Shi L, Pike C, et al. Workplace impacts of anti-TNF therapies in rheumatoid arthritis. Expert Opin Pharmacother 2009;10:255-69
- Halpern MT, Cifaldi MA, Kvien TK. Impact of adalimumab on work participation in rheumatoid arthritis: comparison of an open-label extension study and a registry-based control group. Ann Rheum Dis 2009;68:930-7
- Kavanaugh A, Fleischmann R, Emery P, et al. Clinical, functional and radiographic consequences of achieving stable low disease activity and remission with adalimumab plus methotrexate or methotrexate alone in early rheumatoid arthritis: 26-week results from the randomised, controlled OPTIMA study. Ann Rheum Dis 2013;72:64-71
- Keystone EC, van der Heijde D, Kavanaugh A, et al. Clinical, functional, and radiographic benefits of longterm adalimumab plus methotrexate: final 10-year data in longstanding rheumatoid arthritis. J Rheumatol 2013;40:1487-97
- Singh JA, Furst DE, Bharat A, et al. 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken) 2012;64:625-39
- Romano PS, Roos LL JJ. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J Clin Epidemiol 1993;46:1075-9
- Fitzmaurice G, Laird N, Ware J. Applied Longitudinal Analysis. Hoboken, New Jersey: John Wiley & Sons;2004
- Social Security Administration. Average Wage Index. http://www.ssa.gov/oact/cola/awidevelop.html. Accessed September 21, 2013
- US Census. Income, poverty, and health insurance coverage in the United States: 2012. 2013. United States Census Bureau. https://www.census.gov/hhes/www/hlthins/data/incpovhlth. Accessed October 23, 2013